Back to Search
Start Over
Economic Analysis of National Program for Hepatitis C Elimination, Israel, 2023
- Source :
- Emerging Infectious Diseases. October, 2024, Vol. 30 Issue 10, p2070, 9 p.
- Publication Year :
- 2024
-
Abstract
- Active hepatitis C virus (HCV) prevalence (i.e., HCV PCR positivity) in Israel is estimated to range from 0.1% to >5.5%, depending on risk group affiliation; seroprevalence (i.e., HCV antibody positivity) [...]
Details
- Language :
- English
- ISSN :
- 10806040
- Volume :
- 30
- Issue :
- 10
- Database :
- Gale General OneFile
- Journal :
- Emerging Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.813056853
- Full Text :
- https://doi.org/10.3201/eid3010.240210